Security Name | Ticker | % of Net Assets |
---|---|---|
ELI LILLY & COMPANY | LLY | 3.85% |
UNITEDHEALTH GROUP INC. | UNH | 3.42% |
JOHNSON & JOHNSON | JNJ | 2.95% |
MERCK & COMPANY, INC. | MRK | 2.91% |
ABBVIE INC | ABBV | 2.68% |
THERMO FISHER SCIENTIFIC | TMO | 2.34% |
DANAHER CORPORATION | DHR | 2.08% |
ABBOTT LABORATORIES | ABT | 2.04% |
AMGEN INC. | AMGN | 1.97% |
PFIZER INC | PFE | 1.94% |
ELEVANCE HEALTH INC | ANTM | 1.85% |
INTUITIVE SURGICAL, INC. | ISRG | 1.78% |
BOSTON SCIENTIFIC CORP | BSX | 1.72% |
STRYKER CORP | SYK | 1.67% |
THE CIGNA GROUP | CI | 1.65% |
VERTEX PHARMACEUTICALS | VRTX | 1.61% |
BRISTOL MYERS SQUIBB CO | BMY | 1.53% |
REGENERON PHARMACEUTICALS | REGN | 1.53% |
ASTRAZENECA PLC ADR | AZN | 1.44% |
CVS HEALTH CORP. | CVS | 1.42% |
GILEAD SCIENCES, INC. | GILD | 1.40% |
MCKESSON CORPORATION | MCK | 1.35% |
BECTON DICKINSON & CO | BDX | 1.31% |
HCA HEALTCARE INC | HCA | 1.25% |
MEDTRONIC PLC | MDT | 1.23% |
DEXCOM INC | DXCM | 1.19% |
ZOETIS INC | ZTS | 1.16% |
EDWARDS LIFESCIENCES CORP | EW | 1.12% |
CENCORA INC | ABC | 1.03% |
MODERNA INC | MRNA | 1.01% |
IQVIA HOLDINGS INC | IQV | 1.01% |
CENTENE CORP | CNC | 1.00% |
NOVO-NORDISK A/S -ADR | NVO | 0.97% |
AGILENT TECHNOLOGIES, INC | A | 0.97% |
HUMANA, INC. | HUM | 0.95% |
IDEXX LABORATORIES INC | IDXX | 0.95% |
ICON PLC | ICLR | 0.93% |
GE HEALTHCARE TECHNOLOGY | GEHC | 0.93% |
WEST PHARMACEUTICAL SERVI | WST | 0.88% |
ARGENX SE - ADR | ARGX | 0.86% |
NOVARTIS ADR | NVS | 0.84% |
BIOGEN IDEC, INC. | BIIB | 0.84% |
GSK PLC-SPON ADR | GSK-W | 0.82% |
VEEVA SYSTEMS-A | VEEV | 0.81% |
RESMED INC | RMD | 0.80% |
TEVA PHARMACEUTICAL | TEVA | 0.79% |
ZIMMER BIOMET HOLDINGS IN | ZBH | 0.78% |
CARDINAL HEALTH, INC. | CAH | 0.77% |
ALKERMES PLC | ALKS | 0.75% |
ALIGN TECHNOLOGY | ALGN | 0.75% |
MOLINA HEALTHCARE INC | MOH | 0.72% |
BAXTER INTERNATIONAL | BAX | 0.71% |
BIOMARIN PHARMACEUTICAL | BMRN | 0.69% |
HOLOGIC, INC. | HOLX | 0.68% |
ILLUMINA INC | ILMN | 0.67% |
ALNYLAM PHARMACEUTICALS | ALNY | 0.67% |
AVANTOR INC | AVTR | 0.66% |
LABORATORY CORP OF AMERIC | LH | 0.65% |
QUEST DIAGNOSTICS, INC. | DGX | 0.65% |
COOPER COS INC/THE | COO | 0.64% |
METTLER-TOLEDO INTERNATIO | MTD | 0.63% |
WATERS CORPORATION | WAT | 0.63% |
CRISPR THERAPEUTICS AG | CRSP | 0.62% |
NEUROCRINE BIOSCIENCES IN | NBIX | 0.60% |
SHOCKWAVE MEDICAL INC | SWAV | 0.59% |
ROYALTY PHARMA PLC- CL A | RPRX | 0.59% |
VIATRIS INC | VTRS | 0.57% |
SAREPTA THERAPEU | SRPT | 0.54% |
EXACT SCIENCES | EXAS | 0.54% |
UNITED THERAPEUTICS CORP | UTHR | 0.52% |
NATERA INC | NTRA | 0.52% |
INSULET CORP | PODD | 0.51% |
UNIVERSAL HEALTH SERVICES | UHS | 0.50% |
CATALENT INC | CTLT | 0.50% |
TENET HEALTHCARE CORP | THC | 0.49% |
HENRY SCHEIN, INC. | HSIC | 0.48% |
INCYTE CORP | INCY | 0.47% |
BIO-TECHNE CORP | TECH | 0.46% |
REPLIGEN CORP | RGEN | 0.44% |
EXELIXIS, INC. | EXEL | 0.44% |
CYTOKINETICS INC | CYTK | 0.43% |
INTRA-CELLULAR T | ITCI | 0.43% |
MASIMO CORP | MASI | 0.42% |
HEALTHEQUITY INC | HQY | 0.41% |
BRUKER CORP | BRKR | 0.41% |
MEDPACE HOLDINGS | MEDP | 0.41% |
INSPIRE MEDICAL SYSTEMS I | INSP | 0.41% |
DAVITA, INC | DVA | 0.40% |
REVOLUTION MEDICINES INC | RVMD | 0.40% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 0.40% |
PENUMBRA INC | PEN | 0.39% |
DENTSPLY SIRONA, NC. | XRAY | 0.39% |
ACADIA HEALTHCAR | ACHC | 0.38% |
IONIS PHARMACEUTICALS, IN | IONS | 0.36% |
ROIVANT SCIENCES LTD | ROIV | 0.36% |
BLUEPRINT MEDICI | BPMC | 0.35% |
OPTION CARE HEALTH INC | OPCH | 0.35% |
LANTHEUS HOLDING | LNTH | 0.35% |
HALOZYME THERAPEUTICS INC | HALO | 0.35% |
APELLIS PHARMACE | APLS | 0.32% |
ULTRAGENYX PHARM | RARE | 0.28% |
BRIDGEBIO PHARMA INC | BBIO | 0.27% |
AXSOME THERAPEUT | AXSM | 0.26% |
AZENTA INC | BRKS | 0.24% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.23% |
TELADOC HEALTH INC | TDOC | 0.22% |
GUARDANT HEALTH INC | GH | 0.22% |
INARI MEDICAL INC | NARI | 0.21% |
TG THERAPEUTICS | TGTX | 0.20% |
R1 RCM INC | RCM | 0.20% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.19% |
MADRIGAL PHARMAC | MDGL | 0.13% |
Other (Cash, derivatives and other liabilities) | 0.42% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.